Vitamin D3 receptor — Drug Target

All drugs that target Vitamin D3 receptor — marketed and clinical-stage. Includes 7 drug classes acting on this target.

Drug classes

Vitamin D Analog [EPC] · Vitamin D · Vitamin D2 Analog [EPC] · Vitamin D3 Analog [EPC] · maxacalcitol · tacalcitol · dihydrotachysterol

Marketed (8)

• Dovonex · Vitamin D Analog [EPC] · Immunology
  Calcipotriene works by binding to the Vitamin D3 receptor, which helps to regulate the growth of skin cells and reduce inflammation.
• calcipotriol · NeoStrata Company, Inc. · Immunology
• ELDECALCITOL · Chugai Pharmaceutical Co., Ltd · Metabolic
• Infuvite Adult · Novartis · Vitamin D · Metabolic
• Zemplar · AbbVie · Vitamin D2 Analog [EPC] · Nephrology
  Zemplar works by activating the Vitamin D3 receptor, mimicking the natural effects of Vitamin D to regulate calcium levels and bone health.
• Hectorol · Sanofi · Vitamin D2 Analog [EPC] · Metabolic
  Hectorol works by activating the Vitamin D receptor, which helps regulate calcium levels in the body.
• Zemplar · Danderyd Hospital · Nephrology
• Calcijex · Esjay Pharma · Vitamin D3 Analog [EPC] · Immunology

Phase 3 pipeline (2)

• Oxarol · maxacalcitol · Immunology
  Maxacalcitol works by binding to the Vitamin D3 receptor, which helps regulate skin cell growth and differentiation.
• TACALCITOL · tacalcitol · Immunology
  TACALCITOL works by binding to the Vitamin D3 receptor, which helps to reduce inflammation and modulate the immune response.

Phase 2 pipeline (1)

• Dichystrolum · dihydrotachysterol · Nephrology
  Dichystrolum works by activating the Vitamin D3 receptor to increase calcium levels in the body.